Nuveen Asset Management, LLC Adma Biologics, Inc. Transaction History
Nuveen Asset Management, LLC
- $340 Billion
- Q4 2024
A detailed history of Nuveen Asset Management, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 4,552,317 shares of ADMA stock, worth $66.6 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,552,317
Previous 6,577,877
30.79%
Holding current value
$66.6 Million
Previous $131 Million
40.63%
% of portfolio
0.02%
Previous 0.04%
Shares
23 transactions
Others Institutions Holding ADMA
# of Institutions
400Shares Held
196MCall Options Held
2.08MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21.4MShares$312 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$273 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$187 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$177 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$86.4 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.87B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...